Cargando…

Systematic Analysis of the Literature in Search of Defining Systemic Sclerosis Subsets

OBJECTIVE. Systemic sclerosis (SSc) is a multisystem disease with heterogeneity in presentation and prognosis. An international collaboration to develop new SSc subset criteria is underway. Our objectives were to identify systems of SSc subset classification and synthesize novel concepts to inform d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nevskaya, Tatiana, Pope, Janet E., Turk, Matthew A., Shu, Jenny, Marquardt, April, van den Hoogen, Frank, Khanna, Dinesh, Fransen, Jaap, Matucci-Cerinic, Marco, Baron, Murray, Denton, Christopher P., Johnson, Sindhu R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613330/ https://www.ncbi.nlm.nih.gov/pubmed/33993109 http://dx.doi.org/10.3899/jrheum.201594

Ejemplares similares

State-of-the-art evidence in the treatment of systemic sclerosis
por: Pope, Janet E., et al.
Publicado: (2023)

Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis
por: Becker, Mike, et al.
Publicado: (2019)

Patient perception of disease burden in diffuse cutaneous systemic sclerosis
por: Khanna, Dinesh, et al.
Publicado: (2019)

Factors influencing early referral, early diagnosis and management in patients with diffuse cutaneous systemic sclerosis
por: Distler, Oliver, et al.
Publicado: (2018)

The frequency of uveitis in patients with adult versus childhood spondyloarthritis
por: Turk, Matthew, et al.
Publicado: (2020)

Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort
por: Wu, Wanlong, et al.
Publicado: (2019)

Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review
por: Ross, Laura, et al.
Publicado: (2023)

COVID-19 and systemic sclerosis: Rising to the challenge of a pandemic
por: Denton, Christopher P, et al.
Publicado: (2020)

Registry Evaluation of Digital Ulcers in Systemic Sclerosis
por: Galluccio, Felice, et al.
Publicado: (2010)

Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic review
por: Matteson, Eric L., et al.
Publicado: (2023)

Carotid Artery Atherosclerosis in Patients with Active Rheumatoid Arthritis: Predictors of Plaque Occurrence and Progression Over 24 Weeks
por: Pope, Janet E., et al.
Publicado: (2016)

Treatment of systemic sclerosis: is there any hope for the future?
por: Allanore, Yannick, et al.
Publicado: (2016)

Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO Registry
por: Matucci-Cerinic, Marco, et al.
Publicado: (2016)

The crowded crossroad to angiogenesis in systemic sclerosis: where is the key to the problem?
por: Manetti, Mirko, et al.
Publicado: (2016)

Clinical characteristics and predictors of gangrene in patients with systemic sclerosis and digital ulcers in the Digital Ulcer Outcome Registry: a prospective, observational cohort
por: Allanore, Yannick, et al.
Publicado: (2016)

Systemic sclerosis in the time of COVID-19
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2022)

Cyclophosphamide in systemic sclerosis: still in search of a 'real life' scenario
por: Miniati, Irene, et al.
Publicado: (2009)

Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry
por: Denton, Christopher P, et al.
Publicado: (2012)

Distinct T cell signatures define subsets of patients with multiple sclerosis
por: Johnson, Mark C., et al.
Publicado: (2016)

Nintedanib in Patients With Systemic Sclerosis–Associated Interstitial Lung Disease: Subgroup Analyses by Autoantibody Status and Modified Rodnan Skin Thickness Score
por: Kuwana, Masataka, et al.
Publicado: (2022)

Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial
por: Khanna, Dinesh, et al.
Publicado: (2020)

Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis
por: Manetti, Mirko, et al.
Publicado: (2010)

Clinical trials in systemic sclerosis: lessons learned and outcomes
por: Matucci-Cerinic, Marco, et al.
Publicado: (2007)

Similarities between COVID-19 and systemic sclerosis early vasculopathy: A “viral” challenge for future research in scleroderma
por: Matucci-Cerinic, Marco, et al.
Publicado: (2021)

Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review
por: Fioretto, Bianca Saveria, et al.
Publicado: (2023)

Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosis
por: Fox, David A., et al.
Publicado: (2021)

Arthritis after SARS-CoV-2 infection
por: Baimukhamedov, Chokan, et al.
Publicado: (2021)

Circulating Neurovascular Guidance Molecules and Their Relationship with Peripheral Microvascular Impairment in Systemic Sclerosis
por: Romano, Eloisa, et al.
Publicado: (2022)

Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis
por: Sobanski, Vincent, et al.
Publicado: (2019)

Adipose-derived stem cells: Pathophysiologic implications vs therapeutic potential in systemic sclerosis
por: Rosa, Irene, et al.
Publicado: (2021)

New Insights into Profibrotic Myofibroblast Formation in Systemic Sclerosis: When the Vascular Wall Becomes the Enemy
por: Romano, Eloisa, et al.
Publicado: (2021)

Increased Circulating Soluble Junctional Adhesion Molecules in Systemic Sclerosis: Association with Peripheral Microvascular Impairment
por: Romano, Eloisa, et al.
Publicado: (2022)

Correction to: Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosis
por: Fox, David A., et al.
Publicado: (2021)

A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis
por: Manetti, Mirko, et al.
Publicado: (2014)

Primary Localized Cutaneous Nodular Amyloidosis and Limited Cutaneous Systemic Sclerosis: Additional Cases with Dermatoscopic and Histopathological Correlation of Amyloid Deposition
por: Atzori, Laura, et al.
Publicado: (2021)

Interstitial lung disease in systemic sclerosis: where do we stand?
por: Cappelli, Susanna, et al.
Publicado: (2015)

Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement
por: De Luca, Giacomo, et al.
Publicado: (2021)

Decreased Serum Levels of SIRT1 and SIRT3 Correlate with Severity of Skin and Lung Fibrosis and Peripheral Microvasculopathy in Systemic Sclerosis
por: Manetti, Mirko, et al.
Publicado: (2022)

Tofacitinib in the treatment of skin and musculoskeletal involvement in patients with systemic sclerosis, evaluated by ultrasound
por: Karalilova, Rositsa Valerieva, et al.
Publicado: (2021)

The Treatment of Lung Involvement in Systemic Sclerosis
por: Ruaro, Barbara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d3vboo1p7c34e6o4uirha4e8go